The IDIBAPS Board of Trustees has approved the creation of a new research group. The decision results from a scientific evaluation by the ad hoc comm1
IDIBAPS researchers have reviewed the role of fibroblasts, a type of cell found in the liver, in the progression of liver cancer, both hepatocellular1
Researchers from the Hospital Clínic-IDIBAPS have participated in the preparation of the new guidelines on intrahepatic cholangiocarcinoma, the secon1
The IDIBAPS researcher Josep M. Llovet has participated in the new American AASLD guidelines for the treatment of hepatocellular carcinoma, the most1
The mortality rate during the first month of infection for patients with advanced-stage hepatocellular carcinoma rose to 20.7%.
Researchers at the Hospital Clínic-IDIBAPS and the University of Barcelona have published a review article in the journal Nature Cancer in which they1
A multi-centre study, in which the Clínic-IDIBAPS participated, identified, in nearly 2,500 transplant patients, the main risk factors for the develo1
Immunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in t1
The inhibition of this molecule, in addition to reducing the predisposition towards developing the disease, also reduces the alteration of the microb1
Interview with Dr Maria Reig, head of the Hepatic Oncology Unit
